Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

29 Apr 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed press release on 29th April 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1761.95
Dr. Reddys Labs. 1344.60
Cipla 1358.00
Lupin 1994.65
Zydus Lifesciences 1176.50
View more..